Introduction
Chronic pain affects about 20% of adults, a significant proportion of which involves significant functional, professional and/or mood difficulties, severely reducing quality of life [1] . Among chronic pain conditions, musculoskeletal diseases (mainly affecting the low back and neck) are the most prevalent and the most costly in terms of work absenteeism and disability [1] [2] [3] , despite the availability of evidence-based guidelines [e.g. 4, 5, 6] . This situation suggests that guidelines fail to target treatments to patients who might benefit the most [7] or are not applied correctly. Because the small proportion of chronic patients accounts for most of the economic burden of low back pain (LBP) [8] , patients with acute or subacute pain and presenting a significant risk of developing chronicity might be an important target for tailored strategies: secondary prevention (reducing the impact of a disease or injury, in this case preventing chronicisation of acute or subacute pain) might have a large economic impact. Secondary prevention requires: (1) understanding the factors involved in chronicisation, (2) having validated tools to detect atrisk patients and (3) using validated clinical strategies targeting these risk factors.
The first 2 conditions are met in a relatively satisfactory way: risk factors (''yellow flags'') have been described and several questionnaires have been validated. Indeed, the processes involved in pain chronicisation integrate complex biopsychosocial changes to various degrees, including central nervous system plasticity, changes in motor control, sleep disturbances, and emotional, cognitive, relational and behavioural processes [9] [10] [11] . Risk factors are mainly psychosocial and environmental. The different factors, initially grouped under the term ''yellow flags'', have been subsequently separated into several subcategories [12] . The evidence supporting the prognostic value of these flags is convincing, but their relative importance and validity at the individual level is still debated [12] . Several questionnaires have been validated for detecting these factors, including the STArT Back Screening Tool (SBST) [13] and the Ö rebro Musculoskeletal Pain Screening Questionnaire (OMPSQ) [14, 15] . They have reasonably good sensitivity and specificity and can therefore be used to discriminate patients with low, moderate or high risk of chronicity [16] .
A 2011 literature review [12] observed that despite strong evidence supporting the prognostic value of yellow flags and the fact that these factors are potentially modifiable, only a few studies attempted to link interventions to these factors, and they showed mixed results. Since then, several recent papers [e.g. 17] seemed to lend more evidence for the effectiveness of secondary prevention strategies and provided clinically meaningful protocols. Some investigated how treatments could be adapted to risk levels.
In this systematic review of the literature, we aimed to evaluate the clinical and economic effectiveness of treatment strategies adapted to the risk of chronicisation as compared with treatment as usual in adults with (sub)acute musculoskeletal pain.
Methods
This systematic review followed the PRISMA guidelines [18] . Table 1 gives the details of the literature searches, as defined by the ''PICOS'' and ''STARLITE'' [19] mnemonics, as well as the combinations of key words selected. Because our initial aim was to assess secondary prevention strategies for patients with any cause of musculoskeletal pain (after excluding ''red flags'' such as cancer), keywords such as ''widespread pain'', ''complex regional pain syndrome'' and ''fibromyalgia'' were included. However, our search did not identify any relevant paper relating to these diagnoses. In addition to database searches, the bibliographical collection of the authors of this review as well as the reference lists of relevant papers from the electronic search were screened to identify other potentially relevant studies. After removal of duplicates, all selected records were screened on the basis of the title and abstract. Results from a first PubMed search were screened by 2 authors independently (CM and CD), with any discrepancies resolved by discussion with the third author (AB). After this phase, CM performed a first screening of records identified from the second PubMed search as well as the PEDro searches. Any potentially relevant records were then evaluated by AB. Then, the full texts of all potentially relevant papers were retrieved and assessed by two authors (CM and AB). During the whole process of selection, any discrepancies between 2 reviewers were resolved by discussion with the third author.
The risk of bias, methodological quality and internal validity of individual studies were assessed with the PEDro score [20] . When this score was available from the PEDro database, it was retained, sometimes with slight modifications (reasons for modifications were described). In several instances, the PEDro score was not available from the database. It was then independently calculated by 2 authors (CM and AB), without blinding. Any discrepancies were resolved by consensus.
Unpublished studies were searched in Prospero, ClinicalTrials.gov and the European Union Clinical Trials Register (EudraCT) databases with the same keywords as in the PubMed search.
Results
We selected 13 papers (corresponding to 9 different studies) from an initial 4796 potentially eligible records ( Fig. 1 ). Most studies included patients with LBP, with follow-up from 3 to 12 months. Tables 2 and 3 shows the correspondence of the selected papers to our PICO criteria and the PEDro score, respectively. Three ongoing studies related to our research question were identified in ClinicalTrials.gov and were still recruiting subjects [21, 22, 23] . One ongoing systematic review and meta-analysis was found in Prospero [24] . No relevant study was found in the EudraCT database. We provide below a brief description of all the selected studies, which are summarised in Table 4 .
In an RCT including 654 patients with musculoskeletal pain [25] , the risk of chronicity was measured with a homemade tool, previously validated by the authors, including a 15-item questionnaire and 4 tests by a physiotherapist. Three different treatments were proposed to patients from each of the 3 risk levels; hence, 9 groups of patients were assessed. The only outcome variable was return to work (social security data). Low-risk patients showed no differences between treatments. Medium-risk patients showed a similar benefit with both light and extensive multidisciplinary treatments, better than with treatment as usual. High-risk patients showed improvement with only extensive multidisciplinary treatment. The cost-benefit analysis was positive when treatment assignment was according to the prognosis.
In an RCT comparing functional restoration with ''no intervention'' [26] , the risk of chronicity was assessed with a previously In the no-intervention group, high-risk patients had significantly more disability and healthcare consumption than low-risk patients. High-risk patients who followed the functional restoration programme showed significant improvement. The cost analysis favoured the intervention.
An RCT evaluated the effect of primary-care physiotherapist education on patient outcomes [27] . In this study, physiotherapists specifically learned to identify and address psychosocial prognostic factors (OMPSQ screening, cognitive-behavioural management of fear-avoidance and catastrophic thoughts). Therefore, it can be expected that different interventions were provided to patients with different risk levels (although this was not assessed). No significant differences in patients' outcomes were observed, regardless of the analysis (educated therapists vs. therapists on the waiting list, low-risk vs. high-risk patients). The authors present several possible explanations for this lack of efficacy. The contents of the course may not have been sufficient to change therapists' actual practice behaviour, the course may have been too general and/or too focused on assessment rather than specific treatments. Selection bias and ceiling effects may have occurred with the therapists. As well, high-risk patients may need more extensive multidisciplinary treatment than that provided in this study.
Another study by Hill and colleagues compared the clinical effectiveness and cost-effectiveness of stratified primary care with non-stratified current best practice [17] . With the stratified approach, all patients were given a 30-min assessment and information session, with special emphasis on promoting activity. Standardized physiotherapy addressing symptoms and function was added to the treatment for medium-risk patients. High-risk patients were offered psychologically informed physiotherapy. The control group consisted of patients treated as usual (evidencebased practice). Most primary and secondary outcome measures favoured the intervention. Effect sizes for the Roland-Morris Disability questionnaire were significant for all groups. The lowrisk intervention group showed fewer referrals for further physiotherapy as compared with the control group. By contrast, medium-and high-risk patients received more physiotherapy with the stratified approach. This finding suggests that treatment as usual results in over-treatment of low-risk patients and undertreatment of medium-and high-risk patients. Stratified care also resulted in a significant increase in generic health benefit, at a lower mean cost, and large indirect (productivity) costs saving. Work absenteeism was reduced in all groups. The cost-effectiveness of this stratified approach was confirmed by further analysis [28] .
This stratified approach was evaluated in a primary-care family physician setting [29] . A physician education programme included educational sessions, regular audit, peer feedback, and clinical mentoring opportunities. Physicians were encouraged to refer mediumand high-risk patients to physiotherapy and address their specific risk factors. In total, 15 community-based physical therapists were also trained to this approach [17] . Stratified care led to changes in clinician behaviour, small improvements in patient clinical parameters, a 50% reduction in time off work, savings of direct and indirect costs and increased quality-adjusted life years. Observed changes were less prominent than those measured by Hill and colleagues [17] . However, in this ''real-life'' study, physicians did not always follow the stratified approach. When isolating data for the 71% patients with effective treatment according to the protocol, the effect sizes were similar to those previously described. A detailed cost-effectiveness analysis confirmed the results [30] .
A preliminary study with the same stratified approach and a short-term follow-up [31] gave comparable results. Physiotherapists who stratified patients had better scores at 4 weeks (pain and function indexes) than those who did not.
A stratified approach largely inspired from Hill and colleagues [17] , but in group sessions, was compared with the results from a historical non-stratified control group (patients attending the clinic from November 2009 to October 2011) [32] . Functional improvements for medium-risk patients, who received the same interventions in the stratified and historical groups, were similar in both groups. Low-risk patients performed equally well in both groups, although they received fewer interventions in the stratified arm. High-risk patients showed significantly more improvement with the stratified treatment. This study confirms that low-risk patients do not need intensive treatments and that high-risk patients benefit more from a stratified approach than less intensive interventions. Furthermore, it suggests that the stratified approach can be proposed in a group format, potentially increasing its costeffectiveness.
In addition to the studies described above, a group of 3 randomised controlled studies (RCT) did not correspond to the PICO criteria when taken individually, but grouping them added interesting information, because they evaluated different interventions in patients with different risk levels. Therefore, they bring Our evaluation differs from that of the PEDro database, because the paper explicitly stated no significant differences between the groups; this situation increased the total score by one point as compared to that given in the PEDro database. d In our opinion, this point is met because no patient changed from one group to the other (educated therapists vs. therapists in the waiting list); this situation increased the total score by one point as compared to that given in the PEDro database. interesting information related to the aim of this work [33] [34] [35] . In the first study [33] , a cognitive behavioural therapy (CBT) intervention was compared with information for patients with average OMPSQ scores in the high-risk range. The CBT was superior to the other treatments for most of the outcome variables, but the difference was not always statistically significant. The risk of longterm sick leave was reduced nine-fold. The second study [34] compared the same CBT programme with treatment as usual in a non-patient population, with an average OMPSQ score placing them in the medium range of risk for chronicity. The CBT group showed a significant reduction in sick leave (reduced three-fold) and fear-avoidance; other outcome parameters were not significantly different between groups. In the third study [35] , including patients at low-risk of chronicity, CBT was not superior to back school or treatment as usual in terms of work absenteeism. According to the authors, these 3 studies taken together suggested that the effect size of a CBT intervention is larger for high-risk patients and that it might not be necessary for treating low-risk patients.
Another study from the same group [36] also did not fully meet our PICO criteria. The authors tested more subtle differences in treatment regimen, designed to more closely match patient profiles, in high-risk patients divided into 3 subgroups: medium-risk, fear-avoidant and depressed. Although this study assessed only high-risk patients, it made a further subgrouping and proposed to match treatment to qualitative differences in risk factors (fear-avoidance vs. depression). Three different treatment programmes (activity training, graded exposure in vivo, CBT) were proposed, matched or not to the patient profiles. Therefore, the comparator was not really ''treatment as usual''. All groups showed improvement in primary and secondary outcome parameters. No differences were observed between patients who were matched or unmatched to the treatment, possibly because of overlapping patient profiles and/or treatment contents or because patients were less disabled than in other studies. Thus, this early intervention was associated with improvement, but the matching procedure did not further improve outcomes.
The content and organizational features of treatments found effective for medium-and high-risk groups are summarised in Table 5 . Interventions were proposed in both individual and group sessions, by single therapists (certified behavioural therapist or physiotherapist with special training) or multidisciplinary teams. Usually, 4 to 6 sessions of 1 to 2 hr were proposed. Most programmes included both a CBT component (education and development of coping strategies) and an exercise component (graded activities, physical reconditioning). Other treatment modalities were proposed in some studies (stability exercises, manual therapy, occupational therapy, body awareness, acupuncture).
Discussion
This systematic review was undertaken to evaluate the clinical and economic effectiveness of secondary-prevention stratified strategies of chronic musculoskeletal pain. Only 13 articles, corresponding to 9 different studies (7 RCTs and 2 cohort studies), matched our inclusion criteria, even if 3 studies [33] [34] [35] examined different treatments with different populations. Most of the evidence related to the stratified approach from the Keele group (UK) [17, [28] [29] [30] , further tested in the United States [31, 32] . A Norwegian study [25] with a more extensive treatment, tended to confirm these results. A Swedish group [27, 28, [33] [34] [35] obtained less impressive results, maybe because differences between patient groups and treatment regimens were more subtle than in the other studies.
Overall, these studies show that in primary and secondary care settings, a treatment adapted to the individual characteristics of the patients is more effective, from both a clinical and economic standpoint, than a ''one-size-fits-all'' treatment. Screening tools (SBST or OMPSQ) can be used to subgroup patients and help provide ''the right intervention for the right patient''. Low-risk patients showed no benefit with interventions supplementing usual care (information, reassurance, promotion of activity). Medium-and high-risk patients showed improved physical and emotional functioning as well as an earlier return to work with interventions including both a cognitive-behavioural and an exercise component. The effect size was proportional to the risk level.
Most interventions were provided by physiotherapists, specifically educated to address psychosocial obstacles to recovery. A relatively small number of treatment sessions was sufficient to achieve good results. However, better outcomes were observed in the short than long term (4 vs 12 months) [17] , which suggests that additional treatment sessions might be necessary. The cost-benefit analyses were positive, showing that the higher costs of more intensive interventions were compensated by benefits (return to work) and by lower costs of interventions for low-risk patients. Group interventions seemed to be as effective as individual treatment.
Limitations
The limitations of this review comprise the shortcomings inherent to the included studies as well as limitations relevant to the review process. The main limitation of the studies analysed is their relatively high risk of bias, mostly due to lack of blinding, which is difficult to overcome in physiotherapy and CBT studies. All studies were controlled, but several did not include a randomised design. The ''treatment as usual'', used as a comparator in most studies, varied widely. Most of the outcome measures were subjective (pain, function, mood etc.), thereby adding more methodological difficulties. Outcome parameters were too heterogeneous to allow for meta-analysis.
Concerning the review process, we cannot exclude the existence of negative unpublished trials, although we did not find any of these protocols in the clinical trial registration databases. The screening procedure was not completely homogeneous, because only the first PubMed search was fully screened by 2 authors independently. However, we believe that this adjustment yielded sufficient agreement between the authors to ensure the validity of subsequent screenings.
Concerning the generalisability of our findings, most of the included studies related to LBP, and their applicability to other musculoskeletal pain problems must be questioned. Pain duration was quite heterogeneous. The number of teams actually involved in these studies was limited, and independent validation is needed.
Clinical implications
Four issues are important to establish a secondary prevention programme for musculoskeletal pain: choosing a screening tool, determining treatment regimens for each patient subgroup, ensuring adequate education of the involved professionals, and providing sufficient resources to these professionals to help them effectively provide adequate care.
Choosing a screening tool
Two prognostic screening tools are predominant in the literature: SBST and OMPSQ (original and short versions, with 25 and 10 items, respectively). The SBST is much shorter than the Table 5 Contents of effective treatments for medium-and high-risk groups.
Reference
Linton et al. [33] [34] [35] Haldorsen et al. [25] Gatchel et al. [26] Hill et al. [ original OMPSQ and could neglect several important prognostic factors, but a head-to-head comparison [16] revealed similar psychometric properties. However, the SBST allocated more patients to the medium-risk group and fewer patients to the high-risk group than the OMPSQ. A recent meta-analysis [38] concluded that the OMPSQ performance was ''poor'' for discriminating pain outcomes, ''acceptable'' for disability outcomes and ''excellent'' for work absenteeism outcomes. By contrast, the SBST was ''non-informative'' for pain and ''acceptable'' for disability outcomes, with no data available for absenteeism. The short OMPSQ has similar psychometric properties as the original version [15] . A critical criterion in choosing a screening tool is the purpose of the designed tool: there might be some confusion between prognostic-and treatment-allocating tools. The OMPSQ was constructed from a literature review of psychosocial risk factors for musculoskeletal pain and covers most of these risk factors, so therefore is a prognostic tool, as confirmed by Karran et al. [38] . By contrast, when developing the SBST, only potentially treatmentmodifiable prognostic indicators were chosen [13] . A preliminary conceptual reflexion identified 3 potential patient subgroups and treatments: low-risk (primary care management), high physical risk (physiotherapy), and high psychosocial risk (physical and cognitive-behavioural treatments). Results showed that these subgroups actually corresponded to low, medium, and high risk of chronicity, respectively. The scoring method used in the SBST (including a psychosocial subscale) results in more homogenous patient subgroups with the SBST than the OMPSQ. This situation might account in part for the smaller effect size of the interventions tested by teams using the OMPSQ for patient subgrouping.
Therefore, the OMPSQ is probably a better prognostic tool, whereas the SBST is probably more accurate for treatment allocation in a stratified perspective. Moreover, the SBST is more user-friendly and has been used in most of the effective secondary prevention strategies analysed in our review.
Determining treatment regimens for patient subgroups
''Physiotherapy'' or ''CBT'' are very broad terms and can cover different treatments. For example, ''physiotherapy'' often combines aerobic exercise, graded exercise, strengthening, stretching, massage, use of physical techniques, etc. Therefore, exhaustive descriptions of validated treatments are needed. The Keele team, Fig. 2 . Treatment contents for a stratified approach using the STArT Back Screening Tool as a treatment allocation tool. Table 6 Programmes of education for therapists.
Overmeer et al. [27] Hill et al. [17] ; Foster et al. [29] ; Murphy et al. [32] Details described in Sowden et al. [37] Foster et al. [29] Medium programme Extensive programme working on the stratified approach based on the SBST, has posted useful resources online [39] and provided their therapists with a detailed manual. Their recommendations are summarised in Fig. 2 .
Ensuring adequate education of the involved professionals
The stratified approach highlights the need for specific therapist competencies, such as communication skills, delivering positive messages or patient empowering. The importance of a psychologically informed education of all therapists (nurses, physiotherapists, general practitioners) has been emphasized [40] . Foster and Delitto [41] discussed the numerous challenges of integrating a biopsychosocial perspective into the education of physiotherapists. The modalities of educational programmes described in the studies we selected are summarized in Table 6 . Interactive educational programmes were used, including workshops, case discussions and peer-reviews. The contrast between the results of Overmeer et al. [27] and Hill et al. [17, 29, 32, 36] suggests that detailed but somewhat general education on psychosocial issues is not sufficient to improve patient prognosis. Practical tools, such as the algorithm and detailed manual proposed by Hill and colleagues, are probably needed.
Providing sufficient resources to healthcare providers
The educational programmes we reviewed were quite extensive. Their direct and indirect (loss of productivity) costs should therefore be considered in health policies.
Moreover, evaluating patient representations and beliefs as well as addressing their specific concerns also take time, but the number and duration of sessions are limited in most countries [41] . Reimbursement better adjusted to evidence-based practice is needed, for all involved therapists.
Conclusions and implications for future research
Emerging evidence suggests that a stratified approach to LBP is effective, both in reducing long-term disability in medium-and high-risk patients and in preventing over-treatment of low-risk patients. However, studies are limited and of poor to moderate quality. Further research is needed to confirm these findings and test their external validity. Moreover, the effect size is moderate. Other relevant risk factors (''blue'' and ''black'' flags or emerging factors such as lifestyle [42] ) should also be evaluated and addressed. Another important challenge is to improve the basic and continuous education of healthcare professionals, who need better biopsychosocial knowledge but also better competencies to handle risk factors.
